MARKETSPERPSLIVE45SOCIAL
RESEARCH
Cash
Browse
Live45
Portfolio
Search
Ideas
TrendingElectionsPoliticsSportsCultureCryptoCommoditiesClimateEconomicsMentions

Finance

Tech & Science
Browse
Live45
Portfolio
Search
Ideas
Product
Perpetual FuturesMarketsIncentive programInstitutionsAPI & developers
Company
AboutKalshi ResearchBlogCareersPolicy CenterBrand Kit
Help
Help CenterFAQFee scheduleTrading hoursRegulatory
© 2026 Kalshi Inc. · All rights reserved
PrivacyData Terms of ServiceTrading ProhibitionsFAQ for Finance Professionals
Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.
TrendingElectionsPoliticsSportsCultureCryptoCommoditiesClimateEconomicsMentions

Finance

Tech & Science
All markets
2026 Mega IPOs
Companies
CEOs
IPOs
KPIs
M&A
Product launches
Industries
Healthcare
Technology
Markets
Foreign Exchange
Indices
Interest Rates
Match Ups

Industries

Industries

Week 27: Price of NVIDIA's RTX 5090 compute at end of week?

Above $0.50
1.19x
Above $0.75
8.56x
$26,691 vol5 markets
Industries

Week 27: Price of NVIDIA's B200 compute at end of week?

Above $4.50
2.01x
Above $5.00
6.29x
$16,350 vol9 markets
Industries

July 2026: Monthly average compute price of NVIDIA's RTX 5090

Above $0.50
1.40x
Above $0.75
18.8x
$3,792 vol7 markets
Industries

Week 27: Price of NVIDIA's H200 compute at end of week?

Above $4.00
3.29x
Above $3.50
1.36x
$13,674 vol9 markets
Industries

July 2026: Monthly average compute price of NVIDIA's B200

Above $4.50
1.86x
Above $5.00
3.52x
$8,205 vol9 markets
Industries

July 2026: Monthly average compute price of NVIDIA's H200

Above $4.00
2.66x
Above $3.50
1.42x
$26,391 vol11 markets
Industries

Week 27: Price of NVIDIA's A100 compute at end of week?

Above $1.00
1.55x
Above $1.25
11.7x
$3,059 vol7 markets
Industries

Week 27: Price of NVIDIA's H100 compute at end of week?

Above $2.50
2.59x
Above $2.75
5.90x
$852 vol9 markets
Industries

FDA decision: Gedatolisib by Celcuity Inc. (July 2026)

Full Approval
1.28x
Denied (CRL Issued)
9.41x
$4,511 vol5 markets
Industries

Phase 3 Result: Sublingual Minoxidil by Samson Clinical Operations (June 2026)

No Results
1.02x
Mixed
31.2x
$6,583 vol5 markets
Industries

What will the price of TrendForce's DDR5 be at year-end 2027?

Above $45.00
1.70x
Above $55.00
2.24x
$2 vol9 markets
Industries

FDA decision: Zidesamtinib by Nuvalent (this year)

Yes
1.25x
No
3.40x
$0 vol1 market
Industries

FDA decision: Venglustat by Sanofi (this year)

Yes
1.16x
No
4.51x
$0 vol1 market
Industries

FDA decision: Saroglitazar by Zydus Therapeutics (this year)

Yes
1.31x
No
2.98x
$0 vol1 market
Industries

FDA decision: Rusfertide by Protagonist Therapeutics (this year)

Yes
1.09x
No
6.29x
$0 vol1 market
Industries

FDA decision: Ivonescimab by Summit Therapeutics (this year)

Yes
1.62x
No
2.14x
$75 vol1 market
Industries

FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (this year)

Yes
1.22x
No
3.80x
$25 vol1 market
Industries

FDA decision: Iberdomide by Celgene (this year)

Yes
1.40x
No
2.66x
$13 vol1 market
Industries

FDA decision: DTX401 (pariglasgene brecaparvovec) by Ultragenyx Pharmaceutical (this year)

Yes
1.44x
No
2.59x
$90 vol1 market
Industries

FDA decision: Brepocitinib by Priovant Therapeutics (this year)

Yes
1.22x
No
3.66x
$43 vol1 market
Industries

FDA decision: bictegravir 75 mg/lenacapavir 50 mg (BIC/LEN) by Gilead Sciences (this year)

Yes
1.05x
No
9.41x
$3 vol1 market
Industries

FDA decision: Bepirovirsen by GlaxoSmithKline (this year)

Yes
1.29x
No
3.08x
$0 vol1 market
Industries

FDA decision: BBP-418 by Ml Bio Solutions Inc. (this year)

Yes
1.06x
No
7.85x
$1 vol1 market
Industries

FDA decision: Atacicept by Vera Therapeutics (in July 2026)

Yes
1.09x
No
6.74x
$741 vol1 market